Posts

Chinese aggression another reason to strengthen India-US ties: American lawmakers

Image
The latest Chinese aggression against India is yet another reminder of strong   India-US   ties, top American lawmakers have said. “China’s most recent aggression in   Arunachal Pradesh   is yet another reminder of why a strong security partnership with India is crucial to the national security of the United States and our allies,” India Caucus Co-Chairs said in a statement. “This event marks yet another threat of the People’s Republic of China (PRC) to the Indian territory, including China’s premeditated aggression on the Line of Actual Control in 2020 which saw the death of approximately 20 Indian troops,” the co-chairs said. “As co-chairs of the India Caucus, we have worked for years to deepen the US-India bilateral relationship. The India Caucus built on this progress by including the Khanna-Sherman-Schweikert amendment in the House-passed FY23 NDAA, highlighting the immediate and serious regional border threats that India faces from China,” said the statement. T...

Glenmark becomes first company to launch triple fixed-dose combination for type 2 diabetes in India

Image
“This FDC has been launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg) + Pioglitazone (15 mg) + Metformin (500mg/1000mg) in a sustained release (SR) formulation,” the company stated on Wednesday. This offers patients with Type 2 diabetes the convenience of once-daily dosing to improve their glycemic control and achieve the targeted HbA1c within 24 weeks, the company stated. “Type 2 diabetes patients in India often face issues of beta cell dysfunction along with insulin resistance. In fact, the prevalence of high insulin resistance in India is 38% compared to the global incidence of 15%. Being a leader in diabetes therapy in the country, we are proud to introduce Zita-PioMet, India’s first triple fixed-dose combination for high insulin-resistant type 2 diabetes. The innovative, effective, and affordable drug will help improve glycemic control among adult patients with high HbA1c,” Alok Malik, EVP & Business Head ‐ India Formulations, Glenmark Pharmaceut...